-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on FibroBiologics, Lowers Price Target to $4

Benzinga·11/20/2026 11:52:52
语音播报
HC Wainwright & Co. analyst Matthew Caufield maintains FibroBiologics (NASDAQ:FBLG) with a Buy and lowers the price target from $6 to $4.